Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal pigment epithelial cell | 5 studies | 36% ± 14% | |
astrocyte | 3 studies | 28% ± 7% | |
glutamatergic neuron | 3 studies | 26% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 22% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 99% | 1200.10 | 243 / 245 | 100% | 49.41 | 501 / 502 |
esophagus | 98% | 895.31 | 1414 / 1445 | 74% | 10.62 | 135 / 183 |
stomach | 99% | 1114.42 | 357 / 359 | 57% | 5.26 | 164 / 286 |
lung | 90% | 228.81 | 518 / 578 | 57% | 6.68 | 659 / 1155 |
brain | 97% | 390.86 | 2551 / 2642 | 49% | 1.96 | 345 / 705 |
uterus | 88% | 417.61 | 150 / 170 | 45% | 2.99 | 205 / 459 |
intestine | 66% | 189.76 | 635 / 966 | 57% | 4.01 | 302 / 527 |
bladder | 86% | 540.62 | 18 / 21 | 35% | 2.24 | 174 / 504 |
ovary | 52% | 95.03 | 94 / 180 | 66% | 4.32 | 283 / 430 |
kidney | 96% | 287.98 | 85 / 89 | 12% | 0.89 | 106 / 901 |
blood vessel | 96% | 382.23 | 1288 / 1335 | 0% | 0 | 0 / 0 |
heart | 92% | 630.76 | 788 / 861 | 0% | 0 | 0 / 0 |
muscle | 91% | 289.31 | 733 / 803 | 0% | 0 | 0 / 0 |
skin | 80% | 289.00 | 1453 / 1809 | 7% | 0.31 | 31 / 472 |
liver | 30% | 45.27 | 67 / 226 | 43% | 2.60 | 176 / 406 |
breast | 46% | 83.80 | 210 / 459 | 19% | 1.19 | 216 / 1118 |
adrenal gland | 40% | 50.55 | 104 / 258 | 19% | 0.97 | 44 / 230 |
tonsil | 0% | 0 | 0 / 0 | 58% | 5.79 | 26 / 45 |
pancreas | 10% | 11.70 | 34 / 328 | 43% | 1.82 | 76 / 178 |
adipose | 30% | 46.54 | 366 / 1204 | 0% | 0 | 0 / 0 |
thymus | 10% | 10.62 | 63 / 653 | 8% | 0.39 | 48 / 605 |
eye | 0% | 0 | 0 / 0 | 8% | 0.27 | 6 / 80 |
peripheral blood | 0% | 0.36 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008645 | Biological process | hexose transmembrane transport |
GO_1904659 | Biological process | glucose transmembrane transport |
GO_0072359 | Biological process | circulatory system development |
GO_0012505 | Cellular component | endomembrane system |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016020 | Cellular component | membrane |
GO_0015293 | Molecular function | symporter activity |
GO_0055056 | Molecular function | D-glucose transmembrane transporter activity |
GO_0005355 | Molecular function | glucose transmembrane transporter activity |
Gene name | SLC2A12 |
Protein name | Solute carrier family 2, facilitated glucose transporter member 12 (Glucose transporter type 12) (GLUT-12) |
Synonyms | GLUT12 |
Description | FUNCTION: Insulin-independent facilitative glucose transporter. . |
Accessions | ENST00000275230.6 Q8TD20 |